These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 2818683)
21. White biotechnology: ready to partner and invest in. Kircher M Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821 [TBL] [Abstract][Full Text] [Related]
23. Prescription for an ailing pharmaceutical industry. Demain AL Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826 [No Abstract] [Full Text] [Related]
24. The changing environment for technological innovation in health care. Goodman CS; Gelijns AC Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263 [TBL] [Abstract][Full Text] [Related]
25. The pharmaceutical industry. Lewis L; Siegelman S State Health Care Am; 1993; ():42-9. PubMed ID: 10168060 [TBL] [Abstract][Full Text] [Related]
26. Italy: current trends. Galavotti P Med Device Technol; 2009; 20(1):43-4. PubMed ID: 19370916 [TBL] [Abstract][Full Text] [Related]
30. The reshaping of healthcare. Part 2. Goldsmith JC Healthc Forum J; 1992; 35(4):34-41. PubMed ID: 10171048 [TBL] [Abstract][Full Text] [Related]
31. Editorial: Biotechnology in Korea--the next generation growth engine. Lee SY Biotechnol J; 2008 May; 3(5):562-3. PubMed ID: 18481356 [No Abstract] [Full Text] [Related]
32. Innovation in biotechnology: moving from academic research to product development--the case of biosensors. Siontorou CG; Batzias FA Crit Rev Biotechnol; 2010 Jun; 30(2):79-98. PubMed ID: 20214418 [TBL] [Abstract][Full Text] [Related]
33. Strategic consolidation: the biotechnology business model for the 21st century. Esposito RS; Ostro MJ Nat Biotechnol; 1999 Feb; 17 Suppl():BE16-7. PubMed ID: 10052317 [No Abstract] [Full Text] [Related]
34. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification. Smart A; Martin P Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196 [TBL] [Abstract][Full Text] [Related]
35. Transferring EU-funded biotechnology research to European bioindustry. Lawler C; van der Meer R; Viseur J Nat Biotechnol; 1998 Jun; 16(6):494. PubMed ID: 9624665 [No Abstract] [Full Text] [Related]
36. Modern biotechnology in China. Wang QZ; Zhao XM Adv Biochem Eng Biotechnol; 2010; 122():235-57. PubMed ID: 19626302 [TBL] [Abstract][Full Text] [Related]
37. Today's biotech industry in India. Suresh N Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434 [No Abstract] [Full Text] [Related]
38. The shape of European business in 2003. Wagner M Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520 [No Abstract] [Full Text] [Related]
39. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]